- Report
- May 2022
- 90 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- November 2022
- 734 Pages
Global
From €2404EUR$2,500USD£2,062GBP
- Report
- May 2022
- 72 Pages
Global
From €1923EUR$2,000USD£1,650GBP
- Report
- May 2022
- 102 Pages
Global
From €1923EUR$2,000USD£1,650GBP
- Report
- April 2021
- 35 Pages
Global
From €1923EUR$2,000USD£1,650GBP
- Report
- May 2024
- 50 Pages
Global
From €2548EUR$2,650USD£2,186GBP
- Report
- June 2023
- 120 Pages
China
From €1731EUR$1,800USD£1,485GBP
- Report
- March 2022
Global
From €4663EUR$4,850USD£4,001GBP
- Report
- March 2021
Japan, United States, ... Japan, United States, Europe
From €913EUR$950USD£784GBP
- Report
- February 2020
Japan, United States, ... Japan, United States, Europe
From €913EUR$950USD£784GBP
- Report
- September 2021
- 249 Pages
Global
From €5931EUR$6,168USD£5,088GBP
- Report
- May 2023
- 140 Pages
Global
From €5768EUR$5,999USD£4,948GBP
- Report
- April 2023
- 147 Pages
Global
From €5768EUR$5,999USD£4,948GBP
- Report
- March 2023
- 147 Pages
Global
From €5768EUR$5,999USD£4,948GBP
The Bladder Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat bladder cancer. Bladder cancer is a type of cancer that affects the urinary tract and is the sixth most common type of cancer in the United States. Common treatments for bladder cancer include chemotherapy, radiation therapy, and surgery.
Drugs used to treat bladder cancer are typically classified as either targeted therapies or immunotherapies. Targeted therapies are designed to target specific molecules or pathways in the body that are involved in the growth and spread of cancer cells. Immunotherapies are designed to stimulate the body’s own immune system to fight cancer cells.
Some of the major companies in the Bladder Cancer Drugs market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are involved in the development and sale of drugs used to treat bladder cancer. Show Less Read more